Windtree CEO Craig Fraser retires; Jed Latkin appointed President & CEO effective Dec 1, 2024

WINDTREE THERAPEUTICS INC /DE/

Craig Fraser retires as President and CEO effective Dec 1, 2024, but remains Chairman of the Board.
Jed Latkin, age 50, appointed President and CEO; previously COO and CFO of ProPhase Labs.
Latkin's base salary set at $557,300, with target annual bonus of 50% of base salary.
Latkin eligible for equity award of 2.5% of outstanding shares, subject to shareholder approval.
Employment agreement includes 12-month non-compete and severance benefits for termination without cause or change in control.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Craig Fraser

President and Chief Executive Officer

WINT · WINDTREE THERAPEUTICS INC /DE/

Effective: 2024-12-01
Successor: Jed Latkin
Filed: November 14, 2024, 6:59 PM ET

Craig Fraser will retire as the Company’s President and Chief Executive Officer, effective as of December 1, 2024

Appointed

Jed Latkin

President and Chief Executive Officer

WINT · WINDTREE THERAPEUTICS INC /DE/

Effective: 2024-12-01
Filed: November 14, 2024, 6:59 PM ET

the Company announced the appointment of Jed Latkin, age 50, a current member of the Board, to serve as the Company’s President and Chief Executive Officer, effective as of the Transition Date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Craig Fraser retired as President and Chief Executive Officer at WINDTREE THERAPEUTICS INC /DE/.

Action: retired
Role: President and Chief Executive Officer

Exact text from the filing

Craig Fraser will retire as the Company’s President and Chief Executive Officer, effective as of December 1, 2024

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jed Latkin was appointed as President and Chief Executive Officer at WINDTREE THERAPEUTICS INC /DE/.

Action: appointed
Role: President and Chief Executive Officer

Exact text from the filing

the Company announced the appointment of Jed Latkin, age 50, a current member of the Board, to serve as the Company’s President and Chief Executive Officer, effective as of the Transition Date.

View on SEC.gov

WINDTREE THERAPEUTICS INC /DE/ filing history →

Source: SEC EDGAR

accession 0001437749-24-035033

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.